Role of eIF5A in TNF-α-mediated apoptosis of lamina cribrosa cells

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 10, 2004, Pages 3568-3576

  Taylor, Catherine A ^a   Senchyna, Michelle ^a   Flanagan, John ^a,b   Joyce, Elizabeth M ^a   Cliche, Dominic O ^a   Boone, Adrienne N ^a   Culp Stewart, Shelley ^a   Thompson, John E ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INITIATION FACTOR 5A; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; GLAUCOMA; HOECHST STAINING; HUMAN; HUMAN CELL; HUMAN TISSUE; LAMINA CRIBROSA CELL; NICK END LABELING; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA GANGLION CELL; STAINING; WESTERN BLOTTING;

ADOLESCENT; AGED; AGED, 80 AND OVER; APOPTOSIS; BLOTTING, WESTERN; CAMPTOTHECIN; CELLS, CULTURED; DRUG COMBINATIONS; DRUG SYNERGISM; HUMANS; IN SITU NICK-END LABELING; MALE; OPTIC DISK; PEPTIDE INITIATION FACTORS; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SCLERA; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 4644260398     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-1367     Document Type: Article

References (81)

1. Ritch R, Shields MB, Krupin T, eds. The Glaucomas. Vols. 1 and 2. St. Louis: Mosby; 1996.
2. Hernandez MR, Ye H. Glaucoma: changes in extracellular matrix in the optic nerve head. Ann Med. 1993;25:309-315.
3. Hernandez MR. The optic nerve head in glaucoma: role of astrocytes in tissue remodelling. Prog Retin Eye Res. 2000;19:297-321.
4. Wax MB, Tezel G. Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection. Mol Neurobiol. 2002;26:45-55.
5. Wordinger RJ, Lambert W, Agarwal R, Liu X, Clark AF. Cells of the human optic nerve express glial cell line-derived neurotrophic factor (GDNF) and GDNF receptor complex. Mol Vis. 2003;9:249-256.
6. Lambert W, Agarwal R, Howe W, Clark AF, Wordinger RJ. Neurotrophin and neurotrophin receptor expression by cells of the human lamina cribrosa. Invest Ophthalmol Vis Sci. 2001;42:2315-2323.
7. Garcia-Valenzuela E, Shareef S, Walsh J, et al. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res. 1995;61:33-44.
8. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibaut DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995; 36:774-786.
9. Quigley HA. Ganglion cell death in glaucoma: pathology recapitulates ontongeny. Aust NZ Ophthalmol. 1995;23:85-91.
10. Dreyer EB, Zurakowski D, Shumer RA, Podos SM, Lipton MA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114:299-305.
11. Nickells RW. Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. J Glaucoma. 1996;5:345-356.
12. Bonne C, Muller A. The glaucoma excitotoxicity theory. In: Haefliger IO, Flammer J (eds). Nitric Oxide and Endothelin in the Pathogenesis of Glaucoma. New York, NY: Lippincott-Raven; 1998:205-212.
13. Kashii S. Delayed retinal neuronal death in glaucoma. In: Haefliger IO, Flammer J, eds. Nitric Oxide and Endothelin in the Pathogenesis of Glaucoma. New York, NY: Lippincott-Raven; 1998;221-229.
14. Monard D. Mechanisms of neuronal apoptosis. In: Haefliger IO, Flammer J, eds. Nitric Oxide and Endothelin in the Pathogenesis of Glaucoma. New York, NY: Lippincott-Raven; 1998;213-220.
15. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1998;18:39-57.
16. Morgan JE. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage. Eye. 2000;14:437-444.
17. Armitage RJ. Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol. 1994;6:407-413.
18. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 1994;76:959-962.
19. Feuerstein G, Wang X, Barone FC. Cytokines in brain ischemia: the role of TNF alpha. Cell Mol Neurobiol. 1998;18:695-701.
20. Acarin I, Gonzalez B, Castellano B. Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain. Eur J Neurosci. 2000;12:3505-3520.
21. Stoll G, Jander S, Schroeter M. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv Exp Med Biol. 2002;513:87-113.
22. Wang CX, Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol. 2002;67:161-172.
23. Tezel G, Li LY, Patil RV, Wax MB. TNF-α and TNF-α receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2001;42:1787-1794.
24. Tezel G, Wax MB. Increased production of tumor necrosis factor alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci. 2000;20:8693-8700.
25. Lin H-J, Tsai F-J, Chen W-C, Shi Y-R, Hsu Y, Tsai S-W. Association of tumour necrosis factor alpha-308 gene polymorphism with primary open-angle glaucoma in Chinese. Eye. 2003;17:31-34.
26. Hershey JW, Smit-McBride Z, Schnier J. The role of mammalian initiation factor eIF-4D and its hypusine modification in translation. Biochim Biophys Acta. 1990;1050:160-162.
27. Smit-McBride Z, Schnier J, Kaufman RJ, Hershey JW. Protein synthesis initiation factor eIF-4D: functional comparison of native and unhypusinated forms of the protein. J Biol Chem. 1989;264: 18527-18530.
28. Kang HA, Hershey JW. Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J Biol Chem. 1994;269:3934-3940.
29. Sasaki K, Abid MR, Miyazaki M. Deoxyhypusine synthase gene is essential for cell viability in the yeast Saccharomyces cerevisiae. FEBS Lett. 1996;384:151-154.
30. Schnier J, Schwelberger HG, Smit-McBride Z, Kang HA, Hershey JW. Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae. Mol Cell Biol. 1991;11:3105-3114.
31. Park MH, Joe YA, Kang KR. Deoxyhypusine synthase activity is essential for cell viability in the yeast Saccharomyces cerevisiae. J Biol Chem. 1998;273:1677-1683.
32. Jakus J, Wolff EC, Park MH, Folk JE. Features of the spermidine-binding site of deoxyhypusine synthase as derived from inhibition studies. J Biol Chem. 1993;268:13151-13159.
33. Park MH, Wolff EC, Folk JE. Is hypusine essential for eukaryotic cell proliferation? Trends Biochem Sci. 1993;18:475-479.
34. Hanauske-Abel HM, Slowinska B, Zagulska S, et al. Detection of a sub-set of polysomal mRNAs associated with modulation of hypusine formation at the G1-S boundary: proposal of a role for eIF-5A in onset of DNA replication. FEBS Lett. 1995;366:92-98.
35. Chen ZP, Yan YP, Ding OJ, et al. Effects of inhibitors of deoxyhypusine synthase on the differentiation of mouse neuroblastoma and erythroleukemia cells. Cancer Lett. 1996;105:233-239.
36. Shi XP, Yin KC, Zimolo ZA, Stern AM, Waxman L. The subcellular distribution of eukaryotic translation initiation factor, eIF-5A, in cultured cells. Exp Cell Res. 1996;225:348-356.
37. Xu A, Chen KY. Hypusine is required for a sequence-specific interaction of eukaryotic initiation factor 5A with postsystematic evolution of ligands by exponential enrichment RNA. J Biol Chem. 2001;276:2555-2561.
38. Wang TW, Lu L, Wang D, Thompson JE. Isolation and characterization of senescence-induced cDNAs encoding deoxyhypusine synthase and eucaryotic translation initiation factor 5A from tomato. J Biol Chem. 2001;276:17541-17549.
39. Lee Y, Kim HK, Park HE, Park MH, Joe YA. Effect of N1-guanyl-1,7- diaminoheptane, an inhibitor of deoxyhypusine synthase, on endothelial cell growth, differentiation and apoptosis. Mol Cell Biochem. 2002;237:69-76.
40. Yan X, Tezel G, Wax MB, Edward DP. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch Ophthalmol. 2000;118:666-673.
41. Yuan L, Neufeld AH. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia. 2000;32:42-50.
42. Clark AF, Browder S, Steely HT, Wilson K, Cantu-Crouch D, McCartney MD. Cell biology of the human lamina cribrosa. In: Drance SM, ed. Optic Nerve in Glaucoma. Amsterdam: Kugler Publications; 1995:79-105.
43. Hernandez MR, Igoe F, Neufeld AH. Cell culture of the human lamina cribrosa. Invest Ophthalmol Vis Sci. 1998;29:78-89.
44. Yang P, Hernandez MR. Purification of astrocytes from adult human optic nerve heads by immunopanning. Brain Res Brain Res Protoc. 2003:12:67-76.
45. Naka T, Sugamura K, Hylander BL, Widmer MB, Rustum YM, Repasky EA. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice. Cancer Res. 2002;62:5800-5806.
46. Valente P, Arzani D, Cesario A, Margaritora S, Carbone E, Russo P. TNF increases camptothecin-induced apoptosis by inhibition of NF-kappaB. Eur J Cancer. 2003;39:1468-1477.
47. Arizono Y, Yoshikawa H, Naganuma H, Hamada Y, Nakajima Y, Tasaka K. A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents. Br J Cancer. 2003:88:298-306.
48. Ishitani R, Chuang DM. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arbinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc Natl Acad Sci USA. 1996;93:9937-9941.
49. Ishitani R, Sunaga K, Hirano A, Saunders P, Katsube N, Chuang D-M. Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J Neurochem. 1996;66:928-935.
50. Ishitani R, Kimura M, Sunaga K, Katsube N, Tanaka M, Chuang D-M. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J Pharmacol Exp Ther. 1996;278: 447-454.
51. Madigan MC, Sadun AA, Rao NS, Dugel PU, Tenhula WN, Gill PS. Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits. Neurol Res. 1996;18:176-184.
52. Albon J, Karwatowski WSS, Avery N, et al. Changes in the collagenous matrix of the ageing human lamina cribrosa. Br J Ophthalmol. 1995:79:368-375.
53. Pena JD, Taylor AW, Ricard CS, Vidal I, Hernandez MR. Transforming growth factor beta isoforms in human optic nerve heads. Br J Ophthalmol. 1999:83:209-218.
54. Wordinger RJ, Agarwal R, Talati M, Fuller J, Lambert W, Clark AF. Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol Vis. 2002;8:241-250.
55. Hehlgans T, Mannel DN. The TNF-TNF receptor system. Biol Chem. 2002:383:1581-1585.
56. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol. 2003:66:1403-1408.
57. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003:3:745-756.
58. Orengo E, Noviello G, Cimoli G, et al. Potentiation of Topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation. Jpn J Cancer Res. 1992;83:1132-1136.
59. Yamanaka T, Shiraki K, Sugimoto K, et al. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology. 2000:32:482-490.
60. Shohami E, Ginis I, Hallenbeck JM. Dual role of tumor necrosis factor a in brain injury. Cytokine Growth Factor Rev. 1999;10: 119-130.
61. Ishibashi N, Prokopenko O, Reuhl KR, Mirochnitchenko O. Inflammatory response and glutathione peroxidase in a model of stroke. J Immunol. 2002;168:1926-1933.
62. Botchkina GI, Geimonen E, Bilof ML, Villarreal O, Tracey KJ. Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity. Mol Med. 1999:5:372-381.
63. Irving EA, Hadingham SJ, Roberts J, et al. Decreased nuclear factor-kappaB DNA binding activity following permanent focal cerebral ischaemia in the rat. Neurosci Lett. 2000;288:45-48.
64. Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci. 2000;41:764-774.
65. Hayreh SS. Inter-individual variation in blood supply of the optic nerve head: its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders. Doc Ophthalmol. 1985:59:217-246.
66. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol. 1994;38(suppl):S3-S6.
67. Chung HS, Harris A, Evans DW, Kagemann L, Garzozi HJ, Martin B. Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol. 1999;43(suppl):S43-S50.
68. Neufeld AH, Hernandez MR, Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol. 1997:115:497-503.
69. Liu B, Neufeld AH. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia. 2000:30:178-186.
70. Liu B, Neufeld AH. Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy. Neurobiol Dis. 2003;13:109-123.
71. Caraglia M, Marra M, Giuberti G, et al. The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells. J Biochem (Tokyo). 2003;133:757-765.
72. Barber GN. The interferons and cell death: guardians of the cell or accomplices of apoptosis? Semin Cancer Biol. 2000;10:103-111.
73. Tura BJ, Bunyan KE, Harrison DJ. The effect of IFNgamma on the hepatocyte: cell cycle and apoptosis. Int J Exp Pathol. 2001;82: 317-326.
74. Blanck G. Components of the IFN-gamma signaling pathway in tumorigenesis. Arch Immunol Ther Exp (Warsz). 2002;50:151-158.
75. Morgenegg G, Winkler GC, Hübscher U, Heizmann, CW, Mous J, Kuenzle CC. Glyceraldehyde-3-phosphate dehydrogenase is a non-histone protein and a possible activator of transcription in neurons. J Neurochem. 1986;47:54-62.
76. 4A binding protein. Biochemistry. 1995;34:9700-9707.
77. Ishitani R, Tajima H, Takata H, et al. Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs. Prog Neuropsychopharmacol Biol Psychiatry. 2003:27:291-301.
78. Schulze H, Schuler A, Stüber D, Döbeli H, Langen H, Huber G. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's β-amyloid precursor protein. J Neurochem. 1993;60:1915-1922.
79. Burke JR, Enghild JJ, Martin ME, et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Meet. 1996;2:347-350.
80. Koshy B, Matilla T, Burright EN, et al. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3- phosphate dehydrogenase. Hum Mol Genet. 1996;5:13H-1318.
81. Shohami E, Bass R, Wallach D, Yamin A, Gallily R. Inhibition of tumor necrosis-α (TNF-α) activity in rat brain is associated with cerebroprotection after closed head injury. J Cereb Blood Flow Metab. 1996;16:378-384.